Results 41 to 50 of about 60,506 (251)

Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes.

Journal of the American College of Cardiology, 2019
BACKGROUND The importance of glycosylated hemoglobin A1c (A1c) control as part of comprehensive risk factor management in patients with stable ischemic heart disease (SIHD) and diabetes mellitus (DM) is controversial.
G. Mancini, D. Maron, P. Hartigan, J. Spertus, W. Kostuk, D. Berman, K. Teo, W. Weintraub, W. Boden   +8 more
semanticscholar   +1 more source

What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters [PDF]

, 2016
Diabetes Mellitus (DM) is a syndrome caused by various etiologies. The clinical manifestations of DM are not indicative of the cause of the disease, but might be indicative of the stage and severity of the disease process.
Abdul-Rasoul, Agarwal, Ahlgren, Alejandro, American Diabetes Association, Anderson, Appleton, Atkins, Atkins, Batchelor, Belle, Bostrom, Brackeva, Brenner, Butler, Catchpole, Catchpole, Chiang, Concannon, Coppieters, Cui, Das, Davison, Davison, Davison, De Cock, Eigenmann, Fajans, Fall, Forcada, Forcada, Forsberg, Furrer, Gepts, Gilor, Gilor, Gilor, Girman, Goossens, Gostelow, Gottlieb, Guptill, Haines, Hall, Herold, Hess, Hewson-Hughes, Hoenig, Hoenig, Hoffmann, Holst, Hume, Imamura, Jensen, Kappe, Kennedy, Kenny, Kilpatrick, Kim, Kitamura, Klupa, Kramer, Kramer, Lem, Ling, Link, Lutz, Mattin, McDonald, Miceli, Michels, Neiger, Nelson, Nelson, Niessen, Niessen, Nishii, Orban, Panciera, Papa, Pietropaolo, Porte, Porte, Prahl, Prasad, Rand, Ranta, Reaven, Russell-Jones, Safra, Scudder, Shields, Slingerland, Solanki, Strage, Sun, Temple, Thomas, Vegiopoulos, Verkest, Watson, Watson, Williams, Xenoulis, Yang, Zini, Zini, Zini, Zini, Zini, Zini   +110 more
core   +3 more sources

Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study. [PDF]

, 2009
BACKGROUND: Despite the worldwide increasing burden of diabetes, there has been no corresponding scale-up of treatment in developing countries and limited evidence of program effectiveness.
Marie-Eve Raguenaud, Petros Isaakidis, Tony Reid, Say Chy, Lim Keuky, Gemma Arellano, Wim Van Damme, World Health Organization, D Abegunde, H King, KT Khaw, E Selvin, Diabetes Control and Complications Trial Research Group, AJ Karter, JM Schectman, Y Bezie, KM Fox, B Janssens, GV Gill, WHO Expert Consultation, CE Koro, W Nitiyanant, N Howteerakul, MB Gomes, MC Gulliford, DW Windus, RT Erasmus, D Faeh, CDC, M Mitka, P Bovet, CR Men, DF McLarty, FC Otieno   +33 more
core   +2 more sources

Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes [PDF]

, 2017
Background: Sodium glucose co-transporter 2 (SGLT2) inhibitors may reduce cardiovascular and heart failure risk in patients with type 2 diabetes mellitus (T2DM).
Butler, Javed, Davies, Michael J., Desai, Mehul, Januzzi, James L., Jarolim, Petr, Sattar, Naveed, Vijapurkar, Ujjwala   +6 more
core   +1 more source

Glycosylated haemoglobin. [PDF]

Journal of Clinical Pathology, 1985
NO ...
openaire   +2 more sources

Reference values for laboratory tests of cholesterol, glycosylated hemoglobin and creatinine of the Brazilian adult population.

Revista brasileira de epidemiologia = Brazilian journal of epidemiology, 2019
INTRODUCTION This article aims to estimate reference values for laboratory tests of cholesterol, glycosylated hemoglobin and creatinine for the Brazilian adult population.
C. Szwarcwald, D. Malta, Cimar Azeredo Pereira, André William Figueiredo, W. Almeida, Í. Machado, N. Bacal, A. Silva, Jarbas Barbosa da Silva Júnior, L. G. Rosenfeld   +9 more
semanticscholar   +1 more source

Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review [PDF]

, 2020
Background A growing number of epidemiological studies indicate that metabolic syndrome (MetS) and its associated features play a key role in the development of certain degenerative brain disorders, including Alzheimer’s disease and vascular dementia ...
Bell, J.D., Bell, J.D., Bligh, S.W.A., Bligh, S.W.A., Katsuno, T., Katsuno, T., Parkinson, J., Parkinson, J., Shinjyo, N., Shinjyo, N.   +9 more
core   +1 more source

The SGLT2 inhibitor empagliflozin for the treatment of type 2 diabetes mellitus: A bench to bedside review [PDF]

, 2014
INTRODUCTION: The treatment of type 2 diabetes mellitus (T2DM) continues to pose challenges for clinicians and patients. The dramatic rise in T2DM prevalence, which has paralleled the rise in obesity, has strained the healthcare system and prompted the ...
McGill, Janet B
core   +2 more sources

Practical Focus on American Diabetes Association/European Association for the Study of Diabetes Consensus Algorithm in Patients with Type 2 Diabetes Mellitus: Timely Insulin Initiation and Titration (Iran-AFECT) [PDF]

Diabetes & Metabolism Journal, 2017
BackgroundThe aim of this study was to evaluate the safety and effectiveness of insulin glargine in a large population from a variety of clinical care in Iranian people with type 2 diabetes mellitus (T2DM) and to measure the percentage of patients ...
Mohammad Ebrahim Khamseh, Gholamreza Yousefzadeh, Zahra Banazadeh, Sahar Ghareh   +3 more
doaj   +1 more source

Complications in Infants of Diabetic Mothers Related to Glycated Albumin and Hemoglobin Levels During Pregnancy

Pediatrics and Neonatology, 2016
This study was conducted to investigate whether glycated albumin is a useful glycemic marker from the point of view of infant complications for monitoring glycemic control in pregnant women with diabetes or gestational diabetes mellitus.
Daisuke Sugawara, Asami Maruyama, Toshiyuki Imanishi, Yohei Sugiyama, Ko Ichihashi   +4 more
doaj   +1 more source